Gts Securities »

Intellia Therapeutics shares owned by Gts Securities

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Gts Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $399k 23k 17.27

More positions owned by Gts Securities

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Meta Platforms Cl A (META)
Ishares Tr China Lg-cap Etf (FXI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Netflix (NFLX)
Select Sector Spdr Tr Financial (XLF)

View all positions for Gts Securities

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Morgan Stanley
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
D. E. Shaw & Co
Two Sigma Advisers

View all funds holding Intellia Therapeutics